Misha D. P. Luyer

机构：Radboud University Nijmegen, Catharina Ziekenhuis, Eindhoven University of Technology · ORCID：0000-0002-9483-1520

发表论文 396 篇 · 总被引 12623 次 · h-index 58

代表论文

• Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial (2025 · The Lancet Oncology · 被引 52)
• Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms (2025 · NEJM Evidence · 被引 29)
• Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer (2025 · JAMA Surgery · 被引 12)
• Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve (2025 · British journal of surgery · 被引 9)
• Artificial Intelligence and radiomics models for the diagnosis and prognosis of peritoneal metastases on imaging: a systematic review and meta-analysis (2025 · Computers in Biology and Medicine · 被引 6)
• Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis (2026 · The Lancet Oncology · 被引 4)